Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q3 2018 · 10-Q
Revenue$390.00K$390.00K+15.4% vs Q3 2017 Net Income-$1.69M-$1.69MN/M vs Q3 2017 EPS Diluted-$0.02-$0.02N/M vs Q3 2017 Operating Income-$1,711,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,103,000N/M Margins · derivedOperating margin-438.7%+32.6 pt vs Q3 2017
Net margin-433.8%+80.4 pt vs Q3 2017
ended Apr 30, 2018 · filed Jun 13, 2018 · 44 d after period end